Alternative names (1)
hasBlackBoxWarningRandom triples
| Subject | Object |
|---|---|
| gptkb:Padcev | hyperglycemia |
| gptkb:Padcev | serious skin reactions |
| gptkb:Zohydro_ER | life-threatening respiratory depression |
| gptkb:Uloric | increased risk of cardiovascular death |
| gptkb:Protriptyline | increased risk of suicidal thinking in young people |
| gptkb:Singulair | serious mental health side effects |
| gptkb:lisocabtagene_maraleucel | neurological toxicities |
| gptkb:trastuzumab_deruxtecan | gptkb:interstitial_lung_disease |
| gptkb:Adcetris | gptkb:progressive_multifocal_leukoencephalopathy |
| gptkb:Tagrisso | no |
| gptkb:DB12023 | increased risk of thrombotic events after premature discontinuation |
| gptkb:lisocabtagene_maraleucel | cytokine release syndrome |
| gptkb:Zydelig | yes |
| gptkb:Reglan | tardive dyskinesia |
| gptkb:DB05509 | increased risk of thrombotic events after premature discontinuation |
| gptkb:DB06690 | increased risk of thrombotic events after premature discontinuation |
| gptkb:ticagrelor | bleeding risk |
| gptkb:hydroxyurea | false |
| gptkb:Carvykti | cytokine release syndrome |
| gptkb:Tasigna | QT prolongation |